Patient Pathway Pharmacist - Optimal Drug-related Care
Patient Pathway Pharmacist: Drug Optimisation for Hip Fracture Patients - Facilitating a Safe Patient Handover: a Descriptive Study
Sponsor: Hospital Pharmacy Enterprise, South Eastern Norway
Listed as NCT03695081, this NA trial focuses on Aging and Hip Fractures and remains completed. Sponsored by Hospital Pharmacy Enterprise, South Eastern Norway, it has been updated 11 times since 2018, reflecting substantial change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
11 versions recorded-
Sep 2024 — Present [monthly]
Completed NA
-
Jul 2024 — Sep 2024 [monthly]
Completed NA
-
Jul 2023 — Jul 2024 [monthly]
Completed NA
Status: Active Not Recruiting → Completed
-
May 2023 — Jul 2023 [monthly]
Active Not Recruiting NA
-
May 2022 — May 2023 [monthly]
Active Not Recruiting NA
▶ Show 6 earlier versions
-
Apr 2021 — May 2022 [monthly]
Active Not Recruiting NA
-
Jan 2021 — Apr 2021 [monthly]
Active Not Recruiting NA
-
Sep 2020 — Jan 2021 [monthly]
Active Not Recruiting NA
-
Mar 2020 — Sep 2020 [monthly]
Active Not Recruiting NA
Status: Recruiting → Active Not Recruiting
-
May 2019 — Mar 2020 [monthly]
Recruiting NA
-
Nov 2018 — May 2019 [monthly]
Recruiting NA
First recorded
Sep 2018
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Hospital Pharmacy Enterprise, South Eastern Norway
- Sykehuset i Vestfold HF
For direct contact, visit the study record on ClinicalTrials.gov .